Financial

Shockwave Medical Reports First Quarter 2019 Financial Results

SANTA CLARA, Calif., May 08, 2019 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today reported financial results for the three months ended March 31, 2019. Recent Highlights Recognized revenue of $7.3 million […]

ARCA Biopharma Announces First Quarter 2019 Financial Results and Provides Corporate Update

WESTMINSTER, Colo., May 08, 2019 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today reported financial results for the quarter ended March 31, 2019 and provided a corporate update. “In the first part of this year, we […]

Stereotaxis and Osypka Enter Strategic Collaboration to Advance Robotic Catheter Technology

Development of next generation robotically-navigated magnetic ablation catheter fully owned by Stereotaxis Catheter designed to enhance patient care, improve therapy delivery, simplify catheter navigation, and strengthen commitment to open ecosystem Entered into additional business agreements to support a long-term broad collaboration in electrophysiology ST. LOUIS and RHEINFELDEN, Germany, May 09, […]

Corindus Reports First Quarter 2019 Results

WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, today reported financial results for its first quarter ended March 31, 2019. Recent Financial Highlights and Business Accomplishments: Revenue totaled $3.0 million during the first quarter of 2019, including sale and installation of nine […]

Proteon Therapeutics Announces First Quarter 2019 Financial Results

WALTHAM, Mass., May 08, 2019 (GLOBE NEWSWIRE) — Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with kidney and vascular diseases, today announced its financial results for the quarter ended March 31, 2019, and recent events. Recent Events PATENCY-2 Trial Misses Statistical […]

Radcliffe Group Ltd Appoints Non-Executive Chairman and Chief Scientific Officer

LONDON, May 8, 2019 /PRNewswire/ — Radcliffe Group Ltd (“RG”) announces Professor Andrew Coats (recently Academic Vice President, Monash University and University of Warwick) as Non-Executive Chairman and Dr. Gregory Guillory as Chief Scientific Officer, effective on April 1, 2019. Professor Andrew Coats (top right) is a world-renowned Australian–British academic cardiologist who has a particular interest in the management of heart failure. His research […]